You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
萬邦德(002082.SZ)2019年度淨利潤升86.76%至1.57億元 擬10派1.5元
格隆匯 06-19 22:04

格隆匯 6 月 19日丨萬邦德(002082.SZ)發佈2019年年度報告,實現營業收入157.95億元,同比增長10.18%;利潤總額2.63億元,同比增長83.42%;歸屬於上市公司股東的淨利潤1.57億元,同比增長86.76%;歸屬於上市公司股東的扣除非經常性損益的淨利潤1.52億元,同比增長93.81%;基本每股收益0.66元,擬每10股派發現金紅利1.5元(含税)。經營活動產生的現金流量淨額-2.49億元,上年度則為1.35億元。

報告期內,公司是一家集鋁加工、有色金屬貿易、醫療器械於一體的多元化集團公司。截止報告出具日,公司重大資產重組事項已實施完畢,萬邦德製藥已成為公司全資子公司,公司正式引入醫藥製造業務。萬邦德製藥是一家以國家中藥保護產品、國內獨家生產的銀杏葉滴丸為主導產品,以創建一流藥企為目標的高新技術制藥企業。主營業務為現代中藥、化學原料藥及化學制劑的研發、生產和銷售,擁有完善的藥品研發、生產和銷售體系,具有從中藥提取、原料藥合成到各類劑型製劑生產的完整產業鏈,尤其在呼吸系統、心腦血管和神經系統重大疾病領域的天然植物藥研究與應用方面特色鮮明、優勢明顯。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account